Invention Grant
- Patent Title: Pharmaceutically active disubstituted pyridine derivatives
- Patent Title (中): 药用活性二取代吡啶衍生物
-
Application No.: US14002731Application Date: 2012-03-01
-
Publication No.: US09242937B2Publication Date: 2016-01-26
- Inventor: Gerd Rühter , Peter Nussbaumer , Axel Choidas , Carsten Schulz-Fademrecht , Bert Klebl , Jan Eickhoff
- Applicant: Gerd Rühter , Peter Nussbaumer , Axel Choidas , Carsten Schulz-Fademrecht , Bert Klebl , Jan Eickhoff
- Applicant Address: DE Monheim DE Dortmund
- Assignee: Bayer Intellectual Property GmbH,LEAD DISCOVERY CENTER GMBH
- Current Assignee: Bayer Intellectual Property GmbH,LEAD DISCOVERY CENTER GMBH
- Current Assignee Address: DE Monheim DE Dortmund
- Priority: EP11075038 20110302
- International Application: PCT/EP2012/053517 WO 20120301
- International Announcement: WO2012/117059 WO 20120907
- Main IPC: C07D211/72
- IPC: C07D211/72 ; C07D213/74 ; A61K31/4418 ; A61K45/06
Abstract:
The present invention relates to disubstituted pyridine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted pyridine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said disubstituted pyridine derivatives as inhibitors for a protein kinase.
Public/Granted literature
- US20140296304A1 Pharmaceutically Active Disubstituted Pyridine Derivatives Public/Granted day:2014-10-02
Information query
